Eli Lilly and Company (LLY)

Receivables turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 34,124,100 28,541,400 28,318,400 24,539,800 22,319,500
Receivables US$ in thousands 11,336,200 6,896,000 6,672,800 5,875,300 4,547,300
Receivables turnover 3.01 4.14 4.24 4.18 4.91

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $34,124,100K ÷ $11,336,200K
= 3.01

Lilly(Eli) & Co's receivables turnover has exhibited a gradual decline over the past five years, decreasing from 4.03 in 2019 to 3.01 in 2023. This indicates that the company is taking longer to collect payments from its customers. A lower receivables turnover ratio may suggest a potential issue with the company's credit policy, collection practices, or the quality of its customers. It is essential for Lilly(Eli) & Co to closely monitor and improve its accounts receivable management to ensure timely collections and optimize its working capital efficiency.


Peer comparison

Dec 31, 2023


See also:

Eli Lilly and Company Receivables Turnover